SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile (C. diff) for up to 2 months with no major safety signals, according to a ...

Please provide your email address to receive an email when new articles are posted on . Ninety-five percent of patients achieved treatment success at 8 weeks after administration of Rebyota via ...

The medicine offers a new, potentially life-saving option for a difficult-to-treat condition. “This is such a groundbreaking advancement in the field of medicine,” Sahil Khanna, MBBS, a ...

HealthDay News — The vast majority of patients with recurrent Clostridium difficile infection (CDI) recovered after receiving fecal transplantation via colonoscopy, study findings indicate. Among ...